Optimism rises on combination therapy and protease inhibitor data. Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. The state of the art may have changed since the publication date.
Optimism rises on combination therapy and protease inhibitor data.
Clearinghouse, P.O. Box 6003, Rockville, MD 20849-6003. AIDS Clin Care. The conference's theme was the demise of AZT monotherapy. Data was presented on protease inhibitors, particularly the most potent ones, indinavir and ritonavir , which decrease viral load by two to three logs in some studies. Research is showing viral load to be an excellent marker for clinical decision making.